REM sleep behavior disorder predisposed by neuroleptic malignant syndrome: a case report

Michiko Konno; Takahiro Suzuki; Tadashi Kanamori; Ryuji Furihata; Hiromi Yokose; Hideyuki Kubo; Mayumi Akiyama; Masahiro Suzuki; Makoto Uchiyama

doi:10.1007/s41105-018-0184-4

REM sleep behavior disorder predisposed by neuroleptic malignant syndrome: a case report

Michiko Konno, Takahiro Suzuki, Tadashi Kanamori, Ryuji Furihata, Hiromi Yokose, Hideyuki Kubo, Mayumi Akiyama, Masahiro Suzuki, Makoto Uchiyama

医学部

研究成果: ジャーナルへの寄稿 › 記事 › 査読

抄録

A 44-year-old man was confirmed by polysomnography to have rapid eye movement (REM) sleep behavior disorder (RBD) following recovery from haloperidol- and risperidone-induced neuroleptic malignant syndrome (NMS). RBD symptoms persisted for 30 days. Subsequently, no clinical symptoms or polysomnographic findings of RBD have been observed for 3 years. RBD is reported to be associated with Parkinson’s disease and dementia with Lewy bodies, which involve brainstem dopaminergic hypofunction. However, no reports have documented RBD due to drug-induced dopaminergic hypofunction. This appears to be the first observation of RBD in relation to pharmacological dopaminergic dysfunction.

本文言語	英語
ページ（範囲）	155-157
ページ数	3
ジャーナル	Sleep and Biological Rhythms
巻	17
号	1
DOI	https://doi.org/10.1007/s41105-018-0184-4
出版ステータス	出版済み - 22 1月 2019

文献へのアクセス

10.1007/s41105-018-0184-4

他のファイルとリンク

Scopusの出版物のリンク

引用スタイル

@article{fcc27963c10f4a1dbaddd518dcd7b38c,

title = "REM sleep behavior disorder predisposed by neuroleptic malignant syndrome: a case report",

abstract = "A 44-year-old man was confirmed by polysomnography to have rapid eye movement (REM) sleep behavior disorder (RBD) following recovery from haloperidol- and risperidone-induced neuroleptic malignant syndrome (NMS). RBD symptoms persisted for 30 days. Subsequently, no clinical symptoms or polysomnographic findings of RBD have been observed for 3 years. RBD is reported to be associated with Parkinson{\textquoteright}s disease and dementia with Lewy bodies, which involve brainstem dopaminergic hypofunction. However, no reports have documented RBD due to drug-induced dopaminergic hypofunction. This appears to be the first observation of RBD in relation to pharmacological dopaminergic dysfunction.",

keywords = "Neuroleptic malignant syndrome, REM sleep behavior disorder, REM sleep without muscle atonia",

author = "Michiko Konno and Takahiro Suzuki and Tadashi Kanamori and Ryuji Furihata and Hiromi Yokose and Hideyuki Kubo and Mayumi Akiyama and Masahiro Suzuki and Makoto Uchiyama",

note = "Publisher Copyright: {\textcopyright} 2018, Japanese Society of Sleep Research.",

year = "2019",

month = jan,

day = "22",

doi = "10.1007/s41105-018-0184-4",

language = "English",

volume = "17",

pages = "155--157",

journal = "Sleep and Biological Rhythms",

issn = "1446-9235",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - REM sleep behavior disorder predisposed by neuroleptic malignant syndrome

T2 - a case report

AU - Konno, Michiko

AU - Suzuki, Takahiro

AU - Kanamori, Tadashi

AU - Furihata, Ryuji

AU - Yokose, Hiromi

AU - Kubo, Hideyuki

AU - Akiyama, Mayumi

AU - Suzuki, Masahiro

AU - Uchiyama, Makoto

PY - 2019/1/22

Y1 - 2019/1/22

N2 - A 44-year-old man was confirmed by polysomnography to have rapid eye movement (REM) sleep behavior disorder (RBD) following recovery from haloperidol- and risperidone-induced neuroleptic malignant syndrome (NMS). RBD symptoms persisted for 30 days. Subsequently, no clinical symptoms or polysomnographic findings of RBD have been observed for 3 years. RBD is reported to be associated with Parkinson’s disease and dementia with Lewy bodies, which involve brainstem dopaminergic hypofunction. However, no reports have documented RBD due to drug-induced dopaminergic hypofunction. This appears to be the first observation of RBD in relation to pharmacological dopaminergic dysfunction.

AB - A 44-year-old man was confirmed by polysomnography to have rapid eye movement (REM) sleep behavior disorder (RBD) following recovery from haloperidol- and risperidone-induced neuroleptic malignant syndrome (NMS). RBD symptoms persisted for 30 days. Subsequently, no clinical symptoms or polysomnographic findings of RBD have been observed for 3 years. RBD is reported to be associated with Parkinson’s disease and dementia with Lewy bodies, which involve brainstem dopaminergic hypofunction. However, no reports have documented RBD due to drug-induced dopaminergic hypofunction. This appears to be the first observation of RBD in relation to pharmacological dopaminergic dysfunction.

KW - Neuroleptic malignant syndrome

KW - REM sleep behavior disorder

KW - REM sleep without muscle atonia

UR - http://www.scopus.com/inward/record.url?scp=85059642049&partnerID=8YFLogxK

U2 - 10.1007/s41105-018-0184-4

DO - 10.1007/s41105-018-0184-4

M3 - Article

AN - SCOPUS:85059642049

SN - 1446-9235

VL - 17

SP - 155

EP - 157

JO - Sleep and Biological Rhythms

JF - Sleep and Biological Rhythms

IS - 1

ER -

REM sleep behavior disorder predisposed by neuroleptic malignant syndrome: a case report

抄録

文献へのアクセス

他のファイルとリンク

フィンガープリント

引用スタイル